Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Oct 26 - Oct 31
Life 5: 13063
A 2022 clinical trial funded by Novo Nordisk (which makes Ozempic and Wegovy) found that a weekly dose of one GLP-1 drug reduced heavy-drinking days and total intake for people struggling with alcohol use disorder but only in a subgroup of patients with a BMI over 30
For professional use or clinical inquiries, please contact PLYMOUTH MEDICAL: Citations Nissen, S., & Sharp, R
Cause for Confusion: Noncirrhotic Hyperammonemic Encephalopathy
Oxid Med Cell Longev 2019:9613090 Szarka A, Tomasskovics B, Banhegyi G (2012) The ascorbate-glutathione-alpha-tocopherol triad in abiotic stress response
US$ 24.17
US$ 23.62
US$ 27.62
US$ 21.89
